| |
PRZOOM - /newswire/ -
Portland, OR, United States, 2025/10/29 - Chromatography-Free Forensic Kits Enhance Drug Screening Capabilities, and the Lab Accelerator Program Facilitates Rapid Method and Technology Adoption - SOFT-Tox.org / Bruker.com. NASDAQ: BRKR
|
| |
Bruker Applied Mass Spectrometry will highlight advances in harmonized sample preparation for chromatography-free forensic screening across oral fluid, urine, and blood at the Annual Meeting of the Society of Forensic Toxicologists (SOFT) 2025 in Portland (soft-tox.org), demonstrating DART-MS technology on the EVOQ® DART-TQ⁺ system. The approach overcomes immunoassay screening limitations and challenges, and also adds the advantage of both the fast screen and legally defensible LC-MS confirmation, efficiently done on the same mass spectrometer.
A key focus is the PinPoint Testing DART-ToxBox® Kit, designed for the EVOQ DART-TQ⁺ and validated to ANSI/ASB Standard 036. The kit delivers accuracy, specificity, and sensitivity that outperforms traditional immunoassays, while allowing labs to reflex to LC-MS/MS confirmation on the same instrument. Applications include impaired driving, workplace testing, and bio-surveillance.
Attendees can learn about the Lab Accelerator Program, which helps labs adopt pre-optimized consumables, which minimizes time and effort, speeding up the adoption of new methods and technology.
Bruker will also present the timsMetabo™, bringing on ion-mobility separation to lower mass ranges relevant to drugs of abuse, improving isomer resolution and reducing matrix effects in complex biological samples.
Visit us at Booth #204 or request a demo to explore how these solutions can accelerate your toxicology workflows.
About Bruker Corporation
Bruker (bruker.com) is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics.
|
nora.williams[.]bruker.com 
